全球人工心臟瓣膜市场 - 市场规模（按细分市场）、份额、监管、报销、治疗、预测（~2033 年）

世界上老年人口的不断增长以及心臟瓣膜疾病的相应增加是人造心臟瓣膜市场的主要驱动因素。 瓣膜性心臟病的盛行率随着年龄的增长而增加。 全球有超过 1 亿人受到瓣膜性心臟病的影响，包括瓣膜狭窄和瓣膜逆流。

本报告研究和分析了全球人造心臟瓣膜市场，并提供了有关每个细分市场的市场规模、市场趋势、竞争格局以及 COVID-19 影响的资讯。

市场模型的主要内容如下。

人工心臟瓣膜已经上市以及不断变化的竞争格局

• 对主要产业趋势的考虑
• 人工心臟瓣膜市场各细分市场的年收入及市场前景（2015-2033 年）
• 按细分市场划分的手术总数、单位数量、平均售价和市场价值的详细数据

全球、区域和国家层面的特定市场考量

• 按地区细分全球趋势的特定市场定性资讯和国家/地区考虑因素
• 人工心臟瓣膜市场的SWOT分析
• 人工心臟瓣膜市场竞争动态的思考与趋势

透过对医疗保健系统的真实、全面的了解来促进市场了解。 市场进入部分还提供有关报销政策和监管环境的信息，使您能够更深入地研究市场动态。

• 各国医疗保健系统概览
• 按国家/地区划分的报销政策
• 各国医疗科技监理状况

目标公司

• Edwards Lifesciences Corp
• Abbott Laboratories
• Medtronic Plc
• Corcym UK Ltd
• Artivion Inc
• Lepu Medical Technology (Beijing) Co Ltd
• TTK Healthcare Ltd
• Braile Biomedica Ltda
• 其他

Abstract

Prosthetic Heart Valves Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Prosthetic Heart Valves market for the year 2020 and beyond. Increase in aging population across the globe and the associated valvular degeneration is a major driving factor of the Prosthetic Heart Valve market. Prevalence of valvular heart diseases increases with the age. Globally over 100 million people are affected by Valvular Heart Diseases including cases Valve Stenosis and Regurgitation. Depending on the severity of the condition Valvular Heart Diseases can be treated by surgical repair or replacement procedures using prosthetic heart valves. Mechanical heart valves are generally made of non-physiological materials with a mobile occluder, which is made of rigid materials. This segment comprises of Mechanical Sutured Mitral Valve Replacements and Mechanical Sutured Aortic Valve Replacements.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Prosthetic Heart Valves market and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Prosthetic Heart Valves market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Prosthetic Heart Valves market.
• Competitive dynamics insights and trends provided Prosthetic Heart Valves market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Edwards Lifesciences Corp, Abbott Laboratories, Medtronic Plc, Corcym UK Ltd, Artivion Inc, Lepu Medical Technology (Beijing) Co Ltd, TTK Healthcare Ltd, Braile Biomedica Ltda, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Prosthetic Heart Valves marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Prosthetic Heart Valves market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Prosthetic Heart Valves market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Prosthetic Heart Valves market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Prosthetic Heart Valves market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable